ArkeaBio is a startup based in the United States, most recent round Series A, 3 tracked investors.
Based in the United States, ArkeaBio is a startup founded in 2022. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
ArkeaBio develops a safe, cost-effective methane reducing vaccine to lower emissions from cattle worldwide, targeting methanogenic archaea in the rumen to disrupt methane production at its microbial source.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.